Artal Group as of March 31, 2018
Portfolio Holdings for Artal Group
Artal Group holds 102 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 43.6 | $3.5B | 88M | 39.81 | |
| Weight Watchers International | 23.5 | $1.9B | 29M | 63.72 | |
| Lexicon Pharmaceuticals (LXRX) | 6.2 | $499M | 58M | 8.57 | |
| Spdr S&p 500 Etf (SPY) | 1.6 | $132M | 500k | 263.15 | |
| Bank of America Corporation (BAC) | 1.6 | $131M | 4.4M | 29.99 | |
| General Motors Company (GM) | 1.6 | $127M | 3.5M | 36.34 | |
| Beigene (ONC) | 1.3 | $101M | 600k | 168.00 | |
| Nektar Therapeutics | 1.2 | $96M | 900k | 106.26 | |
| International Business Machines (IBM) | 1.1 | $92M | 600k | 153.43 | |
| Goldman Sachs (GS) | 1.1 | $88M | 350k | 251.86 | |
| Exxon Mobil Corporation (XOM) | 0.9 | $75M | 1.0M | 74.61 | |
| Incyte Corporation (INCY) | 0.9 | $71M | 850k | 83.33 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $72M | 600k | 119.10 | |
| Wells Fargo & Company (WFC) | 0.8 | $68M | 1.3M | 52.41 | |
| Celgene Corporation | 0.7 | $58M | 650k | 89.21 | |
| Chevron Corporation (CVX) | 0.7 | $57M | 500k | 114.04 | |
| Bristol Myers Squibb (BMY) | 0.7 | $57M | 900k | 63.25 | |
| Amicus Therapeutics (FOLD) | 0.6 | $51M | 3.4M | 15.04 | |
| Atara Biotherapeutics | 0.6 | $49M | 1.3M | 39.00 | |
| Blueprint Medicines (BPMC) | 0.6 | $46M | 500k | 91.70 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $45M | 550k | 81.78 | |
| SPDR S&P Biotech (XBI) | 0.6 | $44M | 500k | 87.73 | |
| Tesaro | 0.5 | $43M | 750k | 57.14 | |
| Acceleron Pharma | 0.4 | $33M | 850k | 39.10 | |
| Array BioPharma | 0.4 | $33M | 2.0M | 16.32 | |
| Caterpillar (CAT) | 0.4 | $30M | 200k | 147.38 | |
| Medicines Company | 0.4 | $30M | 900k | 32.94 | |
| Bluebird Bio | 0.3 | $26M | 150k | 170.75 | |
| Avexis | 0.2 | $20M | 160k | 123.58 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $20M | 190k | 104.08 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $17M | 50k | 344.36 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.2 | $18M | 1.0M | 17.57 | |
| Albireo Pharma | 0.2 | $18M | 548k | 32.57 | |
| Alexion Pharmaceuticals | 0.2 | $17M | 150k | 111.46 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $16M | 200k | 81.07 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $16M | 100k | 162.98 | |
| Sage Therapeutics (SAGE) | 0.2 | $16M | 100k | 161.07 | |
| Clovis Oncology | 0.2 | $13M | 250k | 52.80 | |
| Agenus | 0.2 | $13M | 2.8M | 4.71 | |
| Argenx Se (ARGX) | 0.1 | $12M | 150k | 80.44 | |
| Iqiyi (IQ) | 0.1 | $12M | 750k | 15.55 | |
| Accelr8 Technology | 0.1 | $11M | 500k | 22.85 | |
| Fibrogen | 0.1 | $12M | 250k | 46.20 | |
| Radius Health | 0.1 | $11M | 300k | 35.94 | |
| Global Blood Therapeutics In | 0.1 | $9.7M | 200k | 48.30 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $8.9M | 300k | 29.78 | |
| Xencor (XNCR) | 0.1 | $9.0M | 300k | 29.98 | |
| Zafgen | 0.1 | $8.9M | 1.2M | 7.45 | |
| Denali Therapeutics (DNLI) | 0.1 | $8.9M | 450k | 19.69 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $8.3M | 100k | 82.93 | |
| Fate Therapeutics (FATE) | 0.1 | $8.3M | 850k | 9.76 | |
| Zogenix | 0.1 | $8.0M | 200k | 40.05 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $7.8M | 460k | 16.90 | |
| Vital Therapies | 0.1 | $6.8M | 1.0M | 6.80 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $7.5M | 250k | 29.85 | |
| D Stemline Therapeutics | 0.1 | $6.1M | 400k | 15.30 | |
| Wave Life Sciences (WVE) | 0.1 | $6.0M | 150k | 40.10 | |
| Ac Immune Sa (ACIU) | 0.1 | $6.2M | 600k | 10.34 | |
| Glycomimetics | 0.1 | $5.3M | 325k | 16.23 | |
| Cymabay Therapeutics | 0.1 | $5.2M | 400k | 12.99 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $5.9M | 1.9M | 3.08 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $5.3M | 45k | 116.80 | |
| Idera Pharmaceuticals | 0.1 | $5.1M | 2.8M | 1.84 | |
| Akebia Therapeutics (AKBA) | 0.1 | $4.5M | 475k | 9.53 | |
| Dynavax Technologies (DVAX) | 0.1 | $5.0M | 250k | 19.85 | |
| Aduro Biotech | 0.1 | $5.1M | 550k | 9.30 | |
| Audentes Therapeutics | 0.1 | $4.5M | 150k | 30.05 | |
| Spero Therapeutics (SPRO) | 0.1 | $5.0M | 350k | 14.25 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $4.7M | 250k | 18.75 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $4.6M | 300k | 15.44 | |
| Novagold Resources Inc Cad (NG) | 0.1 | $4.3M | 1.0M | 4.33 | |
| Dicerna Pharmaceuticals | 0.1 | $4.1M | 425k | 9.56 | |
| Synlogic | 0.1 | $3.8M | 400k | 9.38 | |
| Inflarx Nv (IFRX) | 0.1 | $3.6M | 125k | 28.84 | |
| Restorbio | 0.1 | $4.3M | 450k | 9.58 | |
| Sangamo Biosciences (SGMO) | 0.0 | $2.9M | 150k | 19.00 | |
| Ironwood Pharmaceuticals (IRWD) | 0.0 | $3.3M | 217k | 15.43 | |
| Tg Therapeutics (TGTX) | 0.0 | $3.6M | 250k | 14.20 | |
| Portola Pharmaceuticals | 0.0 | $3.3M | 100k | 32.66 | |
| Miragen Therapeutics | 0.0 | $3.5M | 500k | 7.01 | |
| Clementia | 0.0 | $3.0M | 200k | 15.15 | |
| Achillion Pharmaceuticals | 0.0 | $2.8M | 750k | 3.71 | |
| Chimerix (CMRX) | 0.0 | $2.6M | 500k | 5.20 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $2.1M | 150k | 14.23 | |
| Adverum Biotechnologies | 0.0 | $2.3M | 400k | 5.80 | |
| Marinus Pharmaceuticals | 0.0 | $1.9M | 500k | 3.82 | |
| Minerva Neurosciences | 0.0 | $1.9M | 300k | 6.25 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $1.3M | 500k | 2.65 | |
| Kura Oncology (KURA) | 0.0 | $1.9M | 100k | 18.75 | |
| Intellia Therapeutics (NTLA) | 0.0 | $1.9M | 90k | 21.09 | |
| Selecta Biosciences | 0.0 | $1.3M | 125k | 10.19 | |
| Krystal Biotech (KRYS) | 0.0 | $1.5M | 150k | 10.09 | |
| Homology Medicines | 0.0 | $1.9M | 100k | 18.70 | |
| Novavax | 0.0 | $1.1M | 500k | 2.10 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $735k | 150k | 4.90 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $1.1M | 150k | 7.20 | |
| Editas Medicine (EDIT) | 0.0 | $829k | 25k | 33.16 | |
| Crispr Therapeutics (CRSP) | 0.0 | $1.1M | 25k | 45.72 | |
| Noveliontherapeuti.. | 0.0 | $897k | 256k | 3.50 | |
| Tocagen | 0.0 | $1.2M | 100k | 11.85 | |
| Solid Biosciences | 0.0 | $1.1M | 150k | 7.50 | |
| Oncocyte | 0.0 | $315k | 150k | 2.10 |
